A SPIDR homozygous nonsense pathogenic variant in isolated primary ovarian insufficiency with chromosomal instability. Issue 2 (9th November 2021)

• Record Type: Journal Article
• Authors: Heddar, Abdelkader; Guichoux, Nathalie; Auger, Nathalie; Misrahi, Micheline
• Is Part Of: Clinical genetics. Volume 101:Issue 2(2022)
• Page Start: 242
• Page End: 246
• Publication Date: 2021-11-09
• Subjects: chromosomal instability -- DNA repair -- mitomycin C -- mutation -- primary ovarian insufficiency -- sister chromatid exchange -- SPIDR; Medical genetics -- Periodicals; 616.0420
• DOI: 10.1111/cge.14080
• Languages: English
• ISSNs: 0009-9163

Abstract

Abstract: Primary ovarian insufficiency (POI), affecting 1% of women under 40 years is a public health problem. Genes involved in meiosis/DNA repair were recently shown to be the leading family of associated causal genes, some of them also cause tumors/cancers. Here, using targeted next‐generation sequencing in an Indian POI patient with primary amenorrhea and streak ovaries, we identified a novel homozygous nonsense variant in exon 7 of SPIDR (KIAA0146) c.814C > T, R272*, predicted to lead a nonsense‐mediated mRNA decay. SPIDR was recently identified by in vitro assays as an auxiliary protein interacting with RAD51 and BLM, two major proteins involved in genome stability. Consistent with alteration of the RAD51 pathway, we observed a strong increase in mitomycin C‐induced DNA breaks and aberrant metaphases in the patient's cells compared to a control. However, sister chromatid exchanges were normal in contrast to the sharp increase characteristic of the BLM pathway. This is the first evidence of chromosomal instability associated with a SPIDR molecular defect, which supports the role of SPIDR in double‐stranded DNA damage repair in vivo in humans and its causal role in POI. Our study increases knowledge on the SPIDR function and has broad implications in the management of such patients. Abstract :